CLICK HERE if you are a Healthcare Professional
Galderma
Roll Over for Important Safety Information

BEFORE AND AFTER

The proof is in the pictures—MetroGel® 1% delivers visible results*

*Actual unretouched photos from clinical trials. Individual results may vary.

Study 301:
Patient ID#: 38











IMPORTANT SAFETY INFORMATION

MetroGel® 1% is indicated for the topical treatment of the inflammatory lesions of rosacea. The following adverse experiences have been reported with the topical use of metronidazole: burning, skin irritation, dryness, transient redness, metallic taste, tingling or numbness of extremities and nausea. MetroGel® 1% gel is contraindicated in individuals with a history of hypersensitivity to metronidazole or any other ingredients in this formulation. For more information about MetroGel®, see Full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.